Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal NPX1 Primary Antibody for EIA, IHC (p) - ABIN359508
Hossain, Russell, OBrien, Laterra: Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2004
Show all 2 references for ABIN359508
Human Polyclonal NPX1 Primary Antibody for EIA, IHC (p) - ABIN359507
Schlimgen, Helms, Vogel, Perin: Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system. in Neuron 1995
Show all 2 references for ABIN359507
Results demonstrate a novel mechanism of neuronal death and predict that inhibition of NP1 expression is a promising strategy to prevent hypoxic-ischemic injury in immature brain
results demonstrate that extracellular release of NP1 promote hypoxic-ischemic neuronal death possibly via surface clustering with GluR1 (show GRIA1 Antibodies) at synaptic sites and that NP1, not its family member NP2 (show NRP2 Antibodies), is involved in the neuronal death mechanisms
Genetic deletion of NP1 prevents hypoxic-ischemic neuronal death by reducing synaptic clustering of GluR1 (show GRIA1 Antibodies).
These findings suggest that Narp (show NPTX2 Antibodies) in the mPFC mediates the extinction of morphine conditioned place preference.
our findings demonstrate a novel mechanism by which NP1 regulates mitochondria-driven hippocampal cell death
NP1 facilitates the accumulation of BCL2-associated X protein (BAX (show BAX Antibodies)) in mitochondria and regulates mitochondrial dynamics during apoptosis in mouse cerebellar granule neurons in culture.
Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3alpha/beta dependent mechanism
data indicate that the loss of NP1/2 disrupts several aspects of retinogeniculate development including the initial establishment of AMPAR transmission and the subsequent elimination of inappropriate circuit connections
The Id3 (show ID3 Antibodies) and NP1 genes become transcriptionally active after MyoD (show MYOD1 Antibodies) induction in undifferentiated myoblasts. This is a stable, heritable event that does not need continued MyoD (show MYOD1 Antibodies) activity & is not subject to negative regulation by activated H-Ras (show HRAS Antibodies) G12V.
Neuronal pentraxin 1 and 2 are necessary for early synaptic refinements in mammalian retina and dorsal lateral geniculate nucleus. May exert their effects through mechanisms paralleling known role of short pentraxins outside the CNS. (Pentraxin 1 (show CRP Antibodies) and 2)
this study shows that NRP1 (show NELL1 Antibodies) can act as a co-receptor for PDGF-D (show PDGFD Antibodies)-PDGFRbeta signaling and is possibly implicated in intercellular communication in the vascular wall
This review provides a general overview of current knowledge of the signalling pathways that are modulated by NRP1 (show NELL1 Antibodies), with particular focus on neuronal and vascular roles in the brain and retina.
This study suggests that NRP1 (show NELL1 Antibodies) expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC (show CYP11A1 Antibodies))of the tongue, whereas the expression of VEGFC (show VEGFC Antibodies), VEGFR3 (show FLT4 Antibodies), CCR7 (show CCR7 Antibodies), and SEMA3E (show SEMA3E Antibodies) are nonindependent predictive factors
Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1 (show NRP1 Antibodies)-mediated internalization reduced viability of breast cancer cells.
Upregulated expression of NRP1 (show NELL1 Antibodies) is associated with glioma.
Studies suggest that the activation of NRP-1 (show NELL1 Antibodies) by PlGF (show PGF Antibodies) directly contributes to tumour aggressiveness and to melanoma escape from anti-VEGF-A (show VEGFA Antibodies) therapies.
REVIEW: Nrp1 (show NELL1 Antibodies) functions in the vasculature is critical for the development of targeted therapeutics for cancer and vascular diseases such as atherosclerosis and retinopathies.
High Expression of Neuropilin-1 (show NRP1 Antibodies) Associates with Hepatocellular Carcinoma.
Increased NRP-1 (show NELL1 Antibodies) expression is associated with metastatic endometrial and lung cancers.
miR (show MLXIP Antibodies)-152 suppression in NSCLC cells might promote neuropilin-1 (show NRP1 Antibodies) mediated cancer metastasis.
This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors\; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. Several alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.
neuronal pentraxin 1
, neuronal pentraxin I
, neuronal pentraxin-1
, 47 kDa taipoxin-binding protein
, transmembrane receptor
, vascular endothelial cell growth factor 165 receptor